SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-10-007231
Filing Date
2010-08-09
Accepted
2010-08-09 14:53:14
Documents
8
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a2199669z10-q.htm 10-Q 485071
2 EXHIBIT 10.1 a2199669zex-10_1.htm EX-10.1 53279
3 EXHIBIT 31.1 a2199669zex-31_1.htm EX-31.1 8075
4 EXHIBIT 31.2 a2199669zex-31_2.htm EX-31.2 8156
5 EXHIBIT 32.1 a2199669zex-32_1.htm EX-32.1 4306
6 EXHIBIT 32.2 a2199669zex-32_2.htm EX-32.2 4391
7 EXHIBIT 99.3 a2199669zex-99_3.htm EX-99.3 93234
8 G128662MQI001.GIF g128662mqi001.gif GRAPHIC 5046
  Complete submission text file 0001047469-10-007231.txt   665163
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16614 | Film No.: 101001198
SIC: 2834 Pharmaceutical Preparations